Previous Close | 1.5000 |
Open | 1.4400 |
Bid | 1.4700 x 1300 |
Ask | 1.5900 x 800 |
Day's Range | 1.4400 - 1.5755 |
52 Week Range | 1.1900 - 36.0000 |
Volume | |
Avg. Volume | 164,230 |
Market Cap | 17.69M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.9110 |
Earnings Date | May 18, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Many of the most successful online businesses rely on experimentation to stay on top. San Francisco startup Eppo wants to help all companies run and manage such tests.
Airbnb's $10 million initiative is a response to travelers' cravings for unique destination rentals.
BERWYN, Pa., May 19, 2022--Virpax® Pharmaceuticals, Inc. ("Virpax") (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of Virpax, will be giving the presentation. Management will also be hosting virtual one-on-one meetings on Wedn